This is a (8mg) blend each of Tesmorelin (6mg) and Ipamorelin (2mg)
Efinopegdutide (JNJ-64565111
Treatment and monitoring of SAGE-DM Currently, there is no specific evidence-based treatment algorithm for SAGE-DM However, the management of SAGE-DM should be adapted from geriatric diabetes guidelines, considering the underlying aging mechanisms that may affect the response to treatment The following recommendations can thus be viewed as an adaptation of standard care within the SAGE-DM conceptual framework rather than a fully validated treatment pathway Monitoring HbA1c may be unreliable in in the elderly due to comorbidities affecting red blood cell lifespan (e.g., advanced kidney disease, GI bleeding, heart valve defects)
Some people may have difficulty getting enough B12 from diet alone, especially those with low intake of animal products, certain digestive conditions, prior weight-loss surgery, or medications that affect absorption
Products are not intended to diagnose, treat, cure, or prevent any disease
Half a billion dollars and a decade of red tape just to get an approval
